Perez K - Search Results

1

Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells.

Mulvey HE, Chang A, Adler J, Del Tatto M, Perez K, Quesenberry PJ, Chatterjee D. Mulvey HE, et al. Among authors: perez k. BMC Cancer. 2015 Aug 1;15:571. doi: 10.1186/s12885-015-1568-3. BMC Cancer. 2015. PMID: 26231887 Free PMC article.

2

Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.

Perez K, Walsh R, Brilliant K, Noble L, Yakirevich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P. Perez K, et al. Exp Mol Pathol. 2013 Aug;95(1):74-82. doi: 10.1016/j.yexmp.2013.01.004. Epub 2013 Mar 22. Exp Mol Pathol. 2013. PMID: 23528430 Free PMC article.

3

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.

Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB, Chatterjee D. Cross-Knorr S, et al. Among authors: perez k. BMC Cancer. 2013 Oct 8;13:463. doi: 10.1186/1471-2407-13-463. BMC Cancer. 2013. PMID: 24098947 Free PMC article.

4

Implications of phytoestrogen intake for breast cancer.

Duffy C, Perez K, Partridge A. Duffy C, et al. Among authors: perez k. CA Cancer J Clin. 2007 Sep-Oct;57(5):260-77. doi: 10.3322/CA.57.5.260. CA Cancer J Clin. 2007. PMID: 17855484 Free article. Review.

5

Advances in the Molecular Profiling of Tumor Tissue.

Resnick MB, Perez K. Resnick MB, et al. Among authors: perez k. R I Med J (2013). 2015 Oct 1;98(10):15. R I Med J (2013). 2015. PMID: 26422539 No abstract available.

6

Updates in Tumor Profiling in Gastrointestinal Cancers.

Perez K, Safran HP. Perez K, et al. R I Med J (2013). 2015 Oct 1;98(10):21-4. R I Med J (2013). 2015. PMID: 26422541

7

Pitfalls of Personalizing Cancer Treatment.

Perez K. Perez K. Am J Clin Oncol. 2016 Feb;39(1):107. doi: 10.1097/COC.0000000000000173. Am J Clin Oncol. 2016. PMID: 26785382 No abstract available.

8

FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.

Safran H, Charpentier KP, Perez K, Mantripragada K, Miner T, DiPetrillo T, Kuritzky B, Apor E, Bishop K, Luppe D, Mitchell K, Rosati K. Safran H, et al. Among authors: perez k. Am J Clin Oncol. 2016 Dec;39(6):619-622. doi: 10.1097/COC.0000000000000246. Am J Clin Oncol. 2016. PMID: 26523444 Clinical Trial.

9

Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial.

Dipetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N, Perez K, Birnbaum A, Battafarano R, Burrows W, Safran H. Dipetrillo T, et al. Among authors: perez k. Am J Clin Oncol. 2012 Feb;35(1):64-7. doi: 10.1097/COC.0b013e318201a126. Am J Clin Oncol. 2012. PMID: 21297434 Clinical Trial.

10

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.

Khurshid H, Dipetrillo T, Ng T, Mantripragada K, Birnbaum A, Berz D, Radie-Keane K, Perez K, Constantinou M, Luppe D, Schumacher A, Leonard K, Safran H. Khurshid H, et al. Among authors: perez k. Front Oncol. 2012 May 31;2:56. doi: 10.3389/fonc.2012.00056. eCollection 2012. Front Oncol. 2012. PMID: 22666662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters